These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18186948)

  • 1. How antimalarial drug resistance affects post-treatment prophylaxis.
    White NJ
    Malar J; 2008 Jan; 7():9. PubMed ID: 18186948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The de novo selection of drug-resistant malaria parasites.
    White NJ; Pongtavornpinyo W
    Proc Biol Sci; 2003 Mar; 270(1514):545-54. PubMed ID: 12641911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.
    Stepniewska K; White NJ
    Antimicrob Agents Chemother; 2008 May; 52(5):1589-96. PubMed ID: 18299409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance.
    White NJ; Pongtavornpinyo W; Maude RJ; Saralamba S; Aguas R; Stepniewska K; Lee SJ; Dondorp AM; White LJ; Day NP
    Malar J; 2009 Nov; 8():253. PubMed ID: 19906307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria.
    O'Meara WP; Smith DL; McKenzie FE
    PLoS Med; 2006 May; 3(5):e141. PubMed ID: 16573365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of drug-resistant malaria: the role of drug elimination half-life.
    Hastings IM; Watkins WM; White NJ
    Philos Trans R Soc Lond B Biol Sci; 2002 Apr; 357(1420):505-19. PubMed ID: 12028788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria Prophylaxis Failure with Doxycycline, Central African Republic, 2014.
    Madamet M; Gaillard T; Velut G; Ficko C; Houzé P; Bylicki C; Mérat S; Houzé S; Taudon N; Michel R; Pasquier P; Rapp C; Pradines B
    Emerg Infect Dis; 2015 Aug; 21(8):1485-6. PubMed ID: 26196738
    [No Abstract]   [Full Text] [Related]  

  • 9. Current methods for the detection of antimalarial drug resistance in Plasmodium parasites infecting humans.
    Slater L; Betson M; Ashraf S; Sargison N; Chaudhry U
    Acta Trop; 2021 Apr; 216():105828. PubMed ID: 33465353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistance.
    Hodel EM; Kabanywanyi AM; Malila A; Zanolari B; Mercier T; Beck HP; Buclin T; Olliaro P; Decosterd LA; Genton B
    PLoS One; 2009 Dec; 4(12):e8184. PubMed ID: 20011529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated pharmacokinetic considerations for the use of antimalarial drugs in pregnant women.
    Moore BR; Davis TM
    Expert Opin Drug Metab Toxicol; 2020 Sep; 16(9):741-758. PubMed ID: 32729740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of antimalarial quality in the emergence and transmission of resistance.
    Brock AR; Ross JV; Parikh S; Esterman A
    Med Hypotheses; 2018 Feb; 111():49-54. PubMed ID: 29406996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recrudescence, Reinfection, or Relapse? A More Rigorous Framework to Assess Chloroquine Efficacy for Plasmodium vivax Malaria.
    Popovici J; Pierce-Friedrich L; Kim S; Bin S; Run V; Lek D; Hee KHD; Lee Soon-U L; Cannon MV; Serre D; Menard D
    J Infect Dis; 2019 Jan; 219(2):315-322. PubMed ID: 30102351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview: clinical pharmacology of antimalarials.
    Karbwang J; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():95-109. PubMed ID: 1364873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why is it that antimalarial drug treatments do not always work?
    White NJ
    Ann Trop Med Parasitol; 1998 Jun; 92(4):449-58. PubMed ID: 9683896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria Surveillance - United States, 2017.
    Mace KE; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2021 Mar; 70(2):1-35. PubMed ID: 33735166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplified antimalarial therapeutic monitoring: using the day-7 drug level?
    White NJ; Stepniewska K; Barnes K; Price RN; Simpson J
    Trends Parasitol; 2008 Apr; 24(4):159-63. PubMed ID: 18353727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resistance to the antimalarial drugs].
    Venanzi E; López-Vélez R
    Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():72-5. PubMed ID: 27608319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.